Free Trial

VanEck Biotech ETF (BBH) Short Interest Ratio & Short Volume

VanEck Biotech ETF logo
$145.19 -0.85 (-0.58%)
As of 10:49 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

VanEck Biotech ETF Short Interest Data

VanEck Biotech ETF (BBH) has a short interest of 6,000 shares. This marks a -46.43% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 8,787 shares to cover all short positions.

Current Short Interest
6,000 shares
Previous Short Interest
11,200 shares
Change Vs. Previous Month
-46.43%
Dollar Volume Sold Short
$915,600.00
Short Interest Ratio
0.5 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
2,290,000 shares
Percentage of Shares Shorted
0.26%
Today's Trading Volume
1,971 shares
Average Trading Volume
8,787 shares
Today's Volume Vs. Average
22%
Short Selling VanEck Biotech ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for VanEck Biotech ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BBH Short Interest Over Time

BBH Days to Cover Over Time

BBH Percentage of Float Shorted Over Time

VanEck Biotech ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20256,000 shares $915,600.00 -46.4%N/A0.5 $152.60
4/15/202511,200 shares $1.65 million +761.5%0.5%1 $147.74
3/31/20251,300 shares $204,542.00 -58.1%0.1%0.1 $157.34
3/15/20253,100 shares $504,246.00 -73.3%0.1%0.3 $162.66
2/28/202511,600 shares $1.91 million +427.3%0.5%1.1 $164.58
2/15/20252,200 shares $353,232.00 -24.1%0.1%0.2 $160.56
1/31/20252,900 shares $479,225.00 +107.1%N/A0.3 $165.25
1/15/20251,400 shares $223,258.00 -17.7%N/A0.1 $159.47
12/31/20241,700 shares $266,849.00 +112.5%N/A0.2 $156.97
12/15/2024800 shares $130,736.00 -96.4%N/A0.1 $163.42
11/30/202422,500 shares $3.77 million +2,712.5%N/A3.7 $167.37
11/15/2024800 shares $126,328.00 +33.3%N/A0.2 $157.91
10/31/2024600 shares $101,778.00 -45.5%N/A0.1 $169.63
10/15/20241,100 shares $196,070.38 +57.1%N/A0.2 $178.25
9/30/2024700 shares $124,173.00 +75.0%N/A0.1 $177.39
9/15/2024400 shares $72,480.00 -55.6%N/A0.1 $181.20
8/31/2024900 shares $163,017.00 -84.2%N/A0.1 $181.13
8/15/20245,700 shares $1.02 million +58.3%N/A0.9 $179.18
7/31/20243,600 shares $649,332.00 -5.3%N/A0.6 $180.37
7/15/20243,800 shares $669,674.00 -57.8%N/A0.6 $176.23
6/30/20249,000 shares $1.52 million -23.7%N/A1.3 $168.41
6/15/202411,800 shares $1.97 million +521.1%N/A1.5 $166.85
5/31/20241,900 shares $312,721.00 -34.5%N/A0.3 $164.59
5/15/20242,900 shares $489,085.00 +38.1%N/A0.4 $168.65
4/30/20242,100 shares $327,684.00 -16.0%N/A0.3 $156.04
4/15/20242,500 shares $387,800.00 -68.0%N/A0.3 $155.12
3/31/20247,800 shares $1.30 million +212.0%N/A0.9 $166.33
3/15/20242,500 shares $407,950.00 +25.0%N/A0.3 $163.18
2/29/20242,000 shares $325,480.00 +185.7%N/A0.2 $162.74
2/15/2024700 shares $114,422.00 -22.2%N/A0.1 $163.46
1/31/2024900 shares $148,950.00 -87.3%N/A0.1 $165.50
1/15/20247,100 shares $1.20 million +97.2%N/A0.5 $168.38
12/31/20233,600 shares $595,116.00 -62.5%N/A0.3 $165.31
12/15/20239,600 shares $1.56 million -43.2%N/A0.8 $162.42
11/30/202316,900 shares $2.56 million +122.4%N/A1.8 $151.70
11/15/20237,600 shares $1.14 million +7.0%N/A1 $150.53
10/31/20237,100 shares $1.03 million -17.4%N/A1 $144.38
10/15/20238,600 shares $1.35 million +53.6%N/A1.2 $156.83
9/30/20235,600 shares $872,088.00 No ChangeN/A0.9 $155.73
9/15/20235,600 shares $897,344.00 -9.7%N/A0.8 $160.24
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
8/31/20236,200 shares $1.01 million +82.4%N/A1 $163.61
8/15/20233,400 shares $551,820.00 +70.0%N/A0.5 $162.30
7/31/20232,000 shares $321,560.00 -23.1%N/A0.3 $160.78
7/15/20232,600 shares $409,292.00 +8.3%N/A0.4 $157.42
6/30/20232,400 shares $374,520.00 -7.7%N/A0.4 $156.05
6/15/20232,600 shares $420,394.00 -13.3%N/A0.4 $161.69
5/31/20233,000 shares $463,890.00 No ChangeN/A0.4 $154.63
5/15/20233,000 shares $483,960.00 -52.4%N/A0.4 $161.32
4/30/20236,300 shares $1.01 million +14.6%N/A0.7 $159.73
4/15/20235,500 shares $913,165.00 +22.2%N/A0.5 $166.03
3/31/20234,500 shares $729,405.00 +95.7%N/A0.4 $162.09
3/15/20232,300 shares $360,479.00 +4.6%N/A0.2 $156.73
2/28/20232,200 shares $343,838.00 -74.1%N/A0.2 $156.29
2/15/20238,500 shares $1.40 million -38.0%N/A0.7 $164.77
1/31/202313,700 shares $2.30 million -38.6%N/A1 $167.74
1/15/202322,300 shares $3.75 million -9.0%N/A1.6 $168.27
12/30/202224,500 shares $3.91 million -9.9%N/A1.9 $159.74
12/15/202227,200 shares $4.51 million +115.9%N/A2 $165.75
11/30/202212,600 shares $2.12 million +106.6%N/A1 $168.16
11/15/20226,100 shares $1.02 million -80.7%N/A0.5 $166.95
10/31/202231,600 shares $4.97 million +182.1%N/A2.4 $157.23
10/15/202211,200 shares $1.63 million No ChangeN/A0.8 $145.46
9/30/20227,500 shares $1.06 million -33.6%N/A0.5 $140.78
9/15/202211,300 shares $1.67 million +41.3%N/A0.7 $147.60
8/31/20228,000 shares $1.17 million -7.0%N/A0.4 $145.98
8/15/20228,600 shares $1.41 million -1.2%N/A0.4 $163.51
7/31/20228,700 shares $1.34 million -44.9%N/A0.3 $154.31
7/15/202215,800 shares $2.41 million -63.3%N/A0.6 $152.63
6/30/202243,100 shares $6.28 million +698.2%N/A1.7 $145.79
6/15/20225,400 shares $734,292.00 +12.5%N/A0.2 $135.98
5/31/20224,800 shares $710,352.00 -61.9%N/A0.2 $147.99
5/15/202212,600 shares $1.80 million -4.6%N/A0.6 $143.14
4/30/202213,200 shares $1.93 million -2.9%N/A0.6 $146.38
4/15/202213,600 shares $2.24 million +18.3%N/A0.6 $164.50
3/31/202211,500 shares $1.86 million -24.3%N/A0.5 $162.13
3/15/202215,200 shares $2.27 million -20.8%N/A0.6 $149.67
2/28/202219,200 shares $3.02 million -27.6%N/A0.7 $157.06
2/15/202226,500 shares $4.24 million -9.6%N/A1 $160.10
1/31/202229,300 shares $4.83 million +67.4%N/A1.2 $164.90
1/15/202217,500 shares $3.04 million -10.7%N/A0.8 $173.62
12/31/202119,600 shares $3.71 million +67.5%N/A1 $189.34
12/15/202111,700 shares $2.24 million -44.0%N/A0.6 $191.44
11/30/202120,900 shares $4.09 million -4.1%N/A1.2 $195.79
11/15/202121,800 shares $4.15 million +28.2%N/A1.4 $190.45
10/29/202117,000 shares $3.39 million -8.1%N/A1.1 $199.50
10/15/202118,500 shares $3.60 million -36.6%N/A1.2 $194.82
9/30/202129,200 shares $5.90 million +9.4%N/A1.8 $202.14
9/15/202126,700 shares $5.75 million -11.6%N/A1.8 $215.28
8/31/202130,200 shares $6.53 million -7.7%N/A2 $216.12
8/13/202132,700 shares $6.93 million +144.0%N/A2 $212.07
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
7/30/202113,400 shares $2.77 million -0.7%N/A0.8 $206.99
7/15/202113,500 shares $2.65 million -20.6%N/A0.9 $196.29
6/30/202117,000 shares $3.43 million -18.7%N/A1.2 $201.67
6/15/202120,900 shares $4.07 million -21.4%N/A1.5 $194.51
5/28/202126,600 shares $4.90 million +33.0%N/A2.3 $184.15
5/14/202120,000 shares $3.47 million +7.5%N/A1.8 $173.72
4/30/202118,600 shares $3.49 million +47.6%N/A1.5 $187.70
4/15/202112,600 shares $2.27 million -8.0%N/A1 $180.28
3/31/202113,700 shares $2.34 million +12.3%N/A1.1 $170.72
3/15/202112,200 shares $2.12 million -15.3%N/A0.9 $174.02
2/26/202114,400 shares $2.57 million -28.7%N/A1 $178.53
2/12/202120,200 shares $3.88 million +59.1%N/A1.2 $191.95
1/29/202112,700 shares $2.32 million -41.7%N/A0.7 $182.68
1/15/202121,800 shares $3.92 million +7.9%N/A1.3 $180.01
12/31/202020,200 shares $3.43 million -8.6%N/A1.2 $169.82
12/15/202022,100 shares $3.86 million -40.6%N/A1.3 $174.74
11/30/202037,200 shares $6.14 million -7.9%N/A2.1 $165.02
11/15/202040,400 shares $6.57 million +12.9%N/A2.2 $162.67
10/30/202035,800 shares $5.59 million -2.2%N/A1.9 $156.14
10/15/202036,600 shares $6.10 million -22.5%N/A0 $166.68
9/30/202047,200 shares $7.65 million -43.6%N/A2 $162.08
9/15/202045,100 shares $7.19 million -46.1%N/A1.6 $159.42
8/31/202083,700 shares $13.43 million -1.0%N/A2.8 $160.45
8/14/202084,500 shares $13.64 million -13.4%N/A2.7 $161.45
7/31/202097,600 shares $16.09 million +4.7%N/A2.9 $164.85
7/15/202093,200 shares $15.87 million -17.7%N/A2.8 $170.33
6/30/2020113,200 shares $18.17 million +141.9%N/A3.3 $160.47
6/15/202046,800 shares $7.31 million +3.5%N/A1.4 $156.15
5/29/202045,200 shares $7.09 million -37.8%N/A1.3 $156.84

BBH Short Interest - Frequently Asked Questions

What is VanEck Biotech ETF's current short interest?

Short interest is the volume of VanEck Biotech ETF shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 6,000 shares of BBH short. Learn More on VanEck Biotech ETF's current short interest.

Is VanEck Biotech ETF's short interest increasing or decreasing?

VanEck Biotech ETF saw a decline in short interest in April. As of April 30th, there was short interest totaling 6,000 shares, a decline of 46.4% from the previous total of 11,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does VanEck Biotech ETF's short interest compare to its competitors?
Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short VanEck Biotech ETF stock?

Short selling BBH is an investing strategy that aims to generate trading profit from VanEck Biotech ETF as its price is falling. BBH shares are trading down $0.85 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against VanEck Biotech ETF?

A short squeeze for VanEck Biotech ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BBH, which in turn drives the price of the stock up even further.

How often is VanEck Biotech ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BBH, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:BBH) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners